Imperial College London

ProfessorRohiniSharma

Faculty of MedicineDepartment of Surgery & Cancer

Professor Clinical Pharmacology and Medical Oncology
 
 
 
//

Contact

 

+44 (0)20 3313 3059r.sharma Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{D'Alessio:2022:10.1200/JCO.2022.40.4_suppl.393,
author = {D'Alessio, A and Weinmann, A and Galle, PR and Fulgenzi, CAM and Bettinger, D and Bengsch, B and Vogel, A and Balcar, L and Scheiner, B and Navaid, M and Naqash, AR and Personeni, N and Pressiani, T and Sharma, R and Pinter, M and Cortellini, A and Rimassa, L and Pinato, DJ},
doi = {10.1200/JCO.2022.40.4_suppl.393},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis},
url = {http://dx.doi.org/10.1200/JCO.2022.40.4_suppl.393},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - D'Alessio,A
AU - Weinmann,A
AU - Galle,PR
AU - Fulgenzi,CAM
AU - Bettinger,D
AU - Bengsch,B
AU - Vogel,A
AU - Balcar,L
AU - Scheiner,B
AU - Navaid,M
AU - Naqash,AR
AU - Personeni,N
AU - Pressiani,T
AU - Sharma,R
AU - Pinter,M
AU - Cortellini,A
AU - Rimassa,L
AU - Pinato,DJ
DO - 10.1200/JCO.2022.40.4_suppl.393
PB - LIPPINCOTT WILLIAMS & WILKINS
PY - 2022///
SN - 0732-183X
TI - Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis
UR - http://dx.doi.org/10.1200/JCO.2022.40.4_suppl.393
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000770995900379&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -